Olanzapine Completed Phase 3 Trials for Pathological Gambling Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00438776Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling